Grace Therapeutics GRCE
NASDAQ GRCE
$1.90 -0.07 (-3.55%)
As of: Oct 22, 2026 · 3:36 PM EDT

Grace Therapeutics (GRCE) Non-Current Deferred Tax Liability (2022 - 2026)

Updated

Grace Therapeutics (GRCE) reported Non-Current Deferred Tax Liability of $612,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 73.5% from $2.31 million a year earlier and unchanged from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Non-Current Deferred Tax Liability (2022 - 2026) Analysis & Trends

Dating back to fiscal Q4 2022, Grace Therapeutics' Non-Current Deferred Tax Liability record includes 18 quarters.

  • Non-Current Deferred Tax Liability has declined for four consecutive fiscal years, with a four-year compound annual growth rate of -56.4% (FY2022 to FY2026).
  • By fiscal year, Non-Current Deferred Tax Liability came in at $2.31 million in FY2025 (-58.1%), $5.51 million in FY2024 (-24.9%), $7.35 million in FY2023 (-56.5%) and $16.89 million in FY2022.
  • Five-year quarterly Non-Current Deferred Tax Liability spans a low of $612,000 in fiscal Q4 2026 and a high of $16.89 million in fiscal Q4 2022.
  • Year over year, Non-Current Deferred Tax Liability has now declined in each of the last 14 quarters, with an average decline of 52.1% over the last eight quarters.
  • Across the past five years, year-over-year decline in Non-Current Deferred Tax Liability ran from 24.9% in fiscal Q4 2024 to 73.5% in fiscal Q4 2026.
  • Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $612,000 (Q4 2026), $2.31 million (Q3 2026) and $2.31 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,170.42 Bn 1,139.01 Bn 19.71 Bn
2 Johnson & Johnson 648.22 Bn 568.08 Bn 17.30 Bn
3 AbbVie 504.43 Bn 477.54 Bn 12.70 Bn
4 Merck 369.14 Bn 323.52 Bn 12.21 Bn
5 Novartis Ag 303.29 Bn 267.28 Bn 11.24 Bn
6 Astrazeneca 268.21 Bn 241.90 Bn 12.86 Bn
7 Amgen 242.56 Bn 197.96 Bn 7.24 Bn
8 Gilead Sciences 194.91 Bn 169.11 Bn 6.22 Bn
9 Pfizer 173.28 Bn 119.92 Bn 10.94 Bn
10 Grace Therapeutics 33.16 Mn -33.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 612,000.00
Mar 31, 2026 612,000.00
Dec 31, 2025 2.31 Mn
Sep 30, 2025 2.31 Mn
Jun 30, 2025 2.31 Mn
Mar 31, 2025 2.31 Mn
Dec 31, 2024 3.33 Mn
Sep 30, 2024 3.94 Mn
Jun 30, 2024 4.79 Mn
Mar 31, 2024 5.51 Mn
Dec 31, 2023 6.40 Mn
Sep 30, 2023 6.61 Mn
Jun 30, 2023 7.06 Mn
Mar 31, 2023 7.35 Mn
Dec 31, 2022 16.22 Mn
Sep 30, 2022 16.49 Mn
Jun 30, 2022 16.65 Mn
Mar 31, 2022 16.89 Mn
API Access

Grace Therapeutics Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=GRCE&period=max&api_key=YOUR_API_KEY